Heterogeneous Polymeric Particles Encapsulating Human T cells for Controlled Activation, Proliferation, and Delivery

Area of Science:

• Biomaterials Science
• Cell Therapy Engineering
• Drug Delivery Systems

Background:

• Cellular therapies require effective delivery platforms for activation, expansion, and controlled release.
• Current methods face challenges in maintaining cell viability and achieving localized therapeutic effects.

Purpose of the Study:

• To introduce toroidal spiral particles (TSPs) as a novel particulate cell delivery platform.
• To demonstrate the engineering flexibility of TSPs for controlling cellular microenvironments and release kinetics.
• To explore the potential of TSPs for adoptive cellular therapy (ACT) in tumor treatment.

Main Methods:

• TSPs were generated via self-assembly of polymeric droplet sedimentation in aqueous solution followed by solidification.
• Engineering design flexibilities were utilized to manipulate the cellular microenvironment.
• Millimeter-size particles with tailored mechanical and physicochemical properties were produced.

Main Results:

• TSPs facilitate continuous cell activation, expansion, and local sustained release.
• The platform allows manipulation of cell proliferation, migration, and release kinetics.
• Biocompatible TSPs possess tunable properties for specific applications.

Conclusions:

• Toroidal spiral particles (TSPs) represent a versatile platform for cell delivery and modulation.
• The engineered properties of TSPs support controlled cellular responses and sustained release.
• TSPs show promise for minimally invasive adoptive cellular therapy delivery to tumor masses.